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Abstract. 
 
CD44 has been identified as a membrane-
binding partner for ezrin/radixin/moesin (ERM) pro-
teins, plasma membrane/actin filament cross-linkers. 
ERM proteins, however, are not necessarily colocalized 
with CD44 in tissues, but with CD43 and ICAM-2 in 
some types of cells. We found that glutathione-S-trans-
ferase fusion proteins with the cytoplasmic domain of 
CD43 and ICAM-2, as well as CD44, bound to moesin 
in vitro. The regions responsible for the in vitro binding 
of CD43 and CD44 to moesin were narrowed down to 
their juxta-membrane 20–30–amino acid sequences in 
the cytoplasmic domain. These sequences and the cyto-
plasmic domain of ICAM-2 (28 amino acids) were all 
characterized by the positively charged amino acid clus-
ters. When E-cadherin chimeric molecules bearing 
these positively charged amino acid clusters of CD44, 
CD43, or ICAM-2 were expressed in mouse L fibro-
blasts, they were co-concentrated with ERM proteins at 
microvilli, whereas those lacking these clusters were 
diffusely distributed on the cell surface. The specific 
binding of ERM proteins to the juxta-membrane posi-
tively charged amino acid clusters of CD44, CD43, and 
ICAM-2 was confirmed by immunoprecipitation and 
site-directed mutagenesis. From these findings, we con-
clude that ERM proteins bind to integral membrane 
proteins bearing a positively charged amino acid cluster 
in their juxta-membrane cytoplasmic domain.
 
E
 
zrin/radixin/moesin 
 
(ERM)
 
1
 
 proteins are thought
to function as general cross-linkers between
plasma membranes and actin filaments (Bretscher,
1983; Pakkanen et al., 1987; Lankes et al., 1988; Tsukita et al.,
1989; Algrain et al., 1993; Arpin et al., 1994; Tsukita et al.,
1997
 
a
 
,
 
b
 
). In cultured cells, ERM proteins are mostly coex-
pressed and concentrated just beneath specialized do-
mains of plasma membranes such as microvilli and cell–
cell or cell–substrate adhesion sites, where actin filaments
are densely associated. In differentiated tissues, however,
their expression levels are specifically regulated (Bretscher,
1983; Pakkanen et al., 1987; Lankes et al., 1988; Tsukita et
al., 1989, 1992; Sato et al., 1991, 1992; Berryman et al.,
1993; Franck et al., 1993; Amieva et al., 1994; Takeuchi et
al., 1994
 
b
 
; Henry et al., 1995). The suppression of ERM
protein expression with antisense oligonucleotides in cul-
tured cells destroys cell surface structures such as mi-
crovilli and cell adhesion sites (Takeuchi et al., 1994
 
b
 
).
Sequencing of cDNAs has revealed that the amino acid
sequence identity among ERM proteins is 70–80% (Gould
et al., 1989; Turunen et al., 1989; Funayama et al., 1991;
Lankes and Furthmayr, 1991; Sato et al., 1992). The se-
quences of their amino-terminal halves are highly con-
served (
 
z
 
85% identity) and homologous to the amino-ter-
minal ends of some membrane-associated proteins, such as
band 4.1 protein, talin, merlin–schwannomin (a tumor sup-
pressor molecule for neurofibromatosis type II), indicating
that the ERM family is included in the band 4.1 superfam-
ily (Conboy et al., 1986; Rees et al., 1990; Rouleau et al.,
1993; Trofatter et al., 1993; Takeuchi et al., 1994
 
a
 
; Arpin
et al., 1994; Tsukita et al., 1997
 
a
 
,
 
b
 
). Because the amino-
terminal domain in band 4.1 protein is responsible for its
direct association with the integral membrane protein, gly-
cophorin C (Bennet, 1989), ERM proteins were thought to
associate with integral membrane proteins through their
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amino-terminal halves (Algrain et al., 1993). Subsequently,
immunoprecipitation studies using cultured cells revealed
that CD44, a widely distributed integral membrane protein,
is associated with ERM proteins (Tsukita et al., 1994).
Recently, in vitro binding analyses revealed that the cyto-
plasmic domain of CD44 directly binds to the amino-termi-
nal half of ERM proteins (Hirao et al., 1996).
An actin filament–binding domain is located at the car-
boxyl-terminal half of each ERM protein, especially the
carboxyl-terminal 34–amino acid residues (Algrain et al.,
1993; Edwards et al., 1994; Turunen et al., 1994; Henry
et al., 1995; Martin et al., 1995; Pestonjamasp et al., 1995).
In full-length native ERM proteins, however, the actin-
binding site as well as the CD44-binding site were re-
ported to be masked through intramolecular and/or inter-
molecular head-to-tail association (Gary and Bretscher,
1993; Algrain et al., 1993; Andréoli et al., 1994; Gary and
Bretscher, 1995; Berryman et al., 1995; Bretscher et al.,
1995; Martin et al., 1995; Tsukita et al., 1997
 
a
 
). Within cells,
some signal must release this masking mechanism for
ERM proteins to function as cross-linkers just beneath the
plasma membrane. Phosphorylation and phosphoinositide
turnover are supposed to be involved in this activation
(Bretscher, 1989; Urushidani et al., 1989; Gary and Bretscher,
1995; Berryman et al., 1995; Chen et al., 1995; Nakamura
et al., 1995; Hirao et al., 1996). In addition, several lines of
evidence indicate that Rho regulates this activation in vivo
(Hirao et al., 1996; Mackay et al., 1997; Tsukita et al.,
1997
 
a
 
,
 
b
 
).
Although CD44 is precisely colocalized with ERM pro-
teins in cultured fibroblasts (Tsukita et al., 1994), the ex-
pression of CD44 varies among tissues and its distribution
is not necessarily identical to those of ERM proteins in tis-
sues or in cultured epithelial cells (Berryman et al., 1995;
von Andrian et al., 1995; Nakamura and Ozawa, 1996).
Furthermore, targeted disruption of CD44 in MDAY-D2
lymphosarcoma cells had no effect on their growth or met-
astatic capacity, suggesting that the actin filament/plasma
membrane linkage was normal in these CD44-deficient
cells (Driessens et al., 1995). In some types of cells, inte-
gral membrane proteins such as the H
 
1
 
/K
 
1
 
 ATPase,
CD43, and ICAM-2 are precisely colocalized with ERM
proteins (Hanzel et al., 1991; Yonemura et al., 1993; He-
lander et al., 1996). In this study, we showed that moesin
binds in vitro to the cytoplasmic domains of CD43 and
ICAM-2 as well as CD44. The regions responsible for
moesin binding in their cytoplasmic domains were nar-
rowed down to the juxta-membrane regions that were
characterized by positively charged amino acid clusters.
The involvement of these juxta-membrane regions in their
ERM binding was also confirmed by transfection and im-
munoprecipitation. Based on these findings, we concluded
that ERM proteins bind to integral membrane proteins
bearing a positively charged amino acid cluster just be-
neath the plasma membrane.
 
Materials and Methods
 
Cells and Antibodies
 
Sf9 and High Five cells (Invitrogen, Carlsbad, CA) were cultured in TC-
100 medium (GIBCO BRL, Gaithersburg, MD) supplemented with tryp-
tose phosphate broth (GIBCO BRL) and 10% FCS at 27
 
8
 
C. Mouse fibro-
blastic L cells (Earle, 1943) were cultured in DME with 10% FCS.
We detected ERM proteins, using mouse anti-ERM mAb, CR22 (Sato
et al., 1991), which has higher affinity for moesin than for ezrin and ra-
dixin, rat antiezrin mAb (M11), rat antiradixin mAb (R2-1), rat anti-
moesin mAb (M22), and rabbit anti-ERM pAb (TK89) (Takeuchi et al.,
1994
 
b
 
). TK89 recognizes ezrin, radixin, and moesin both by immunoblot-
ting and immunofluorescence microscopy. Rat anti–E-cadherin mAb
(ECCD-2; Shirayoshi et al., 1986) was provided by M. Takeichi (Kyoto
University, Kyoto, Japan).
 
Production and Purification of
Glutathione-S-Transferase (GST) Fusion Proteins with 
Cytoplasmic Domains of Integral Membrane Proteins
 
Various cDNA fragments for mouse CD44 and mouse ICAM-2 were ob-
tained by reverse transcriptase-polymerase chain reaction, using mouse
lung total RNA as a template, and those for rat CD43 were generated by
PCR, using LSP-1 (Yonemura et al., 1993) as a template. They were then
subcloned into pBluescript SK
 
2
 
 (Stratagene, La Jolla, CA) and con-
firmed by sequencing with an ABI PRISM cycle sequencing kit (Perkin-
Elmer Corp., Foster City, CA).
The PCR products subcloned into pBluescript SK
 
2
 
 were excised and
subcloned into pGEX2T vector (Pharmacia Diagnostics AB, Uppsala,
Sweden) to produce GST fusion proteins with full-length and various
truncated cytoplasmic domains of CD44 and CD43. The cytoplasmic do-
main of mouse CD44 contains 70 amino acids (He et al., 1992), and the
following GST–CD44 cytoplasmic domain fusion proteins were produced
(Fig. 1 
 
a
 
): G-44 containing the whole cytoplasmic domain of amino acids
(a.a.)1–70, G-44/1–19 containing a.a.1–19, G-44/1–31 containing a.a.1–31
plus RN at the carboxyl terminus as a result of construction, and G-44/19–70
containing a.a.19–70. The cytoplasmic domain of rat CD 43 contains 124
amino acids (Killeen et al., 1987), and the following GST–CD43 cytoplas-
mic domain fusion proteins were produced (see Fig. 1 
 
a
 
): G-43 containing
the entire cytoplasmic domain of a.a.1–124, G-43/1–31 containing a.a.1–31
plus INSS at the carboxyl terminus, G-43/1–39 containing a.a.1–39 plus
EFIVTD, G-43/1–64 containing a.a.1–64 plus EFIVTD, G-43/38–124
containing a.a.38–124, G-43/62–124 containing a.a.62–124, and G-43/78–
124 containing a.a.78–124. The cytoplasmic domain of mouse ICAM-2
contains 28 amino acids (Xu et al., 1992), so only G-ICAM-2 containing
the whole cytoplasmic domain was produced. We produced GST fusion
proteins with the whole cytoplasmic domain of mouse E-cadherin (G-
Ecad; Nagafuchi et al., 1987) and occludin (G-Oc; Furuse et al., 1994) as
controls. Site-directed mutagenesis was performed by PCR, using appro-
priate mutagenic primers in pBluescript SK
 
2
 
 vectors containing cDNAs
encoding CD44, CD43, or ICAM-2 (see Fig. 8).
The GST fusion proteins were produced and purified basically accord-
ing to the method of Smith and Johnson (1988) in 
 
Escherichia coli
 
 JM109
or HB101 cells. Synthesis of the GST fusion proteins was induced by incu-
bating bacteria with 0.2 mM isopropyl 
 
b
 
-
 
d
 
-thiogalactopyranoside for 2–5 h
at 37
 
8
 
C. The cells were sedimented by centrifugation and the cell pellet
was solubilized in buffer A (20 mM Tris buffer, pH 8.0, 150 mM NaCl,
1 mM EDTA, 1 mM DTT, 1.5% Sarkosyl, 1 mM PMSF, 20 
 
m
 
g/ml leupep-
tin) at 4
 
8
 
C according to the method of Frangioni and Neel (1993). Sarko-
syl effectively decreased degradation of the fusion proteins during purifi-
cation, which had not been technically circumvented in our previous study
using 
 
E. coli
 
 (Hirao et al., 1996). After sonication, the cell debris was re-
moved by centrifugation (10,000 
 
g
 
, 10 min, at 4
 
8
 
C) and the supernatant
was mixed with an equal volume of buffer B (the same as buffer A except
that 5% Triton X-100 was used instead of sarkosyl). The supernatant was
mixed with glutathione-Sepharose 4B beads (Pharmacia Diagnostics AB)
that had been washed with buffer C (1:1 mixture of buffers A and B) and
then gently shaken for 10–30 min at 4
 
8
 
C. The beads were washed with
buffer C to remove unbound bacterial proteins and stored on ice. The
amount of GST fusion protein bound to the beads was estimated by SDS-
PAGE.
 
In Vitro Binding Assay between ERM Proteins and GST 
Fusion Proteins
 
Mouse ezrin, radixin, and moesin were produced by recombinant baculo-
virus infection and purified as described (Hirao et al., 1996). For each re-
action, 15–60 
 
m
 
l of glutathione-Sepharose bead slurry containing a GST
fusion protein was suspended in 1 ml of buffer D (10 mM Hepes buffer,
pH 7.5, 40 or 150 mM KCl, 1 mM MgCl
 
2
 
, 1 mM EGTA, 1 mM DTT, 2 
 
m
 
g/ 
Yonemura et al. 
 
Binding Partners for ERM Proteins
 
887
 
ml leupeptin) in a 1.5-ml tube, and recovered as a pellet by centrifugation
(10,000 
 
g
 
, 1 min). After removing the supernatant, the pellet was resus-
pended in 1 ml of buffer D and this wash was repeated three times. Ezrin,
radixin, or moesin was added to make 100–200 
 
m
 
l of bead suspension in
buffer D containing 0.5–1 
 
m
 
g of ERM proteins. The beads were incubated
for 30 min at room temperature with occasional mixing, and washed five
times with buffer D by centrifugation. GST fusion protein was eluted with
its associated protein using 150 
 
m
 
l of 50 mM Tris buffer (pH 8.0) contain-
ing 30 mM glutathione. The amount of GST fusion protein in each eluate
was determined by SDS-PAGE. An appropriate amount of each eluate
was again subjected to SDS-PAGE to contain the same amount of GST
fusion protein. The amount of bound ERM protein was determined by
immunoblotting with specific mAbs followed by densitometric scanning
using a software NIH Image V1.54 and then relative amount of moesin
bound per GST fusion protein (mol) was calculated.
 
SDS-PAGE and Immunoblotting
 
SDS-PAGE (12.5 or 10%) was performed according to the conventional
method, and gels were stained with Coomassie brilliant blue R-250. For
immunoblotting, proteins were electrophoretically transferred from gels
onto nitrocellulose membranes. After incubation with first antibody,
bound antibodies were visualized using biotinylated secondary antibody
followed by avidin-conjugated alkaline phosphatase.
 
Mammalian Expression Vectors and Transfection
 
As shown in Fig. 1 
 
b
 
, a series of E-cadherin chimeric proteins with full-
length or truncated cytoplasmic domains of mouse CD44, rat CD43, and
mouse ICAM-2 were expressed in mouse L cells as described (Yonemura
et al., 1993). These constructs corresponded to those of various GST fu-
sion proteins (see Fig. 1 
 
a
 
). Appropriate restriction sites were introduced
into the cDNA fragments obtained by PCR as described above, and sub-
cloned into the pBATEM2 vector, which was designed for E-cadherin ex-
pression (Nagafuchi et al., 1987; Nose et al., 1988). All chimeric constructs
consisted of the extracellular domain of mouse E-cadherin (from the
amino terminus to BstPI site) and several amino acids of the extracellular
domain/transmembrane domain/cytoplasmic domain of CD44, CD43, or
ICAM-2.
All E-cadherin/CD44 chimeric molecules contained four amino acids
of the extracellular domain of CD44. In E-44/20–70, N in the transmem-
brane domain located near the transmembrane–cytoplasmic junction was
converted to T. All E-cadherin/CD43 chimeric molecules contained 23
amino acids of the extracellular domain of CD43. Both E-43/1–31 and
E-43/1–47 contained additional PGIL at the carboxyl terminus, and E-43/
1–9,49–124 contained RSA between amino acids 9 and 49. In our previous
study, E-43, E-43/1–47, and E-43/1–9,49–124 were called CLS-1, CLS1-A,
and CLS1-B, respectively (Yonemura et al., 1993). The E-cadherin/
ICAM-2 chimera (E-ICAM-2) contained 3 amino acids of the extracellu-
lar domain of ICAM-2. Site-directed mutagenesis was performed by PCR
using appropriate mutagenic primers in pBluescript SK
 
2
 
 vectors contain-
ing cDNAs encoding E-44, E-43, or E-ICAM-2 (see Fig. 8).
L cells were transfected with DNA using lipofectin or lipofectamine re-
agent (GIBCO BRL). Cells cultured on coverslips were washed twice with
Opti-MEM (GIBCO BRL), and were incubated for 3–5 h with 1 ml Opti-
MEM containing 1 
 
m
 
g of plasmid DNAs and 10 
 
m
 
l of the reagents, fol-
lowed by the addition of 3 ml of normal medium containing FCS. Cells
were then cultured for 2–3 d. L cells were also transfected by microinjec-
tion using a set of manipulators (MN-188 and MO-189; Narishige, Tokyo,
Japan) connected to a microinjector 5242 (Eppendorf, Inc., Hamburg,
Germany). Expression vectors in injection buffer (100 mM KCl, 10 mM
Hepes buffer, pH 7.5) were injected into the nuclei of cells cultured on
coverslips. Cells were examined 12–24 h after injection.
 
Immunofluorescence Microscopy
 
All procedures were performed at room temperature. Cells were fixed
with 1–4% fresh formaldehyde in 0.1 M Hepes buffer (pH 7.5) for 10–15
min. After three washes with PBS containing 30 mM glycine (G-PBS),
cells were soaked in blocking solution (G-PBS containing 2% normal goat
Figure 1. Structure of GST fusion proteins
(a) and E-cadherin chimeric proteins (b) of
entire or truncated cytoplasmic domain of
CD44, CD43, or ICAM-2. Details are de-
scribed in Materials and Methods. 
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serum) for 5 min and incubated with anti–E-cadherin mAb (ECCD-2) di-
luted with the blocking solution for 30 min. The cells were then washed
three times with G-PBS, treated with 0.2% Triton X-100 in G-PBS for 10
min, and washed with G-PBS. The cells were soaked in blocking solution
for 10 min, incubated with CR22 for 30 min, washed three times with
G-PBS, and incubated with secondary antibodies. FITC-conjugated goat
anti–rat Ig antibody (Biosource, Camarillo, CA) and rhodamine-conju-
gated goat anti–mouse IgG antibody (Chemicon International, Inc., Te-
mecula, CA) were used as secondary antibodies. Cells were washed three
times, and then mounted in 90% glycerol-PBS containing 0.1% para-phe-
nylendiamine and 1% 
 
n
 
-propylgalate. Specimens were observed using a
Zeiss Axiophot photomicroscope (Carl Zeiss, Oberkochen, Germany).
Images were taken on T-MAX 400 film (Eastman Kodak Co., Rochester,
NY), or recorded with a cooled CCD camera (SenSys 0400, 768X512 pix-
els; Photometrics, Tucson, AZ) controlled by a Power Macintosh 7600/132
and the software package IPLab Spectrum V3.1 (Signal Analytics Corp.,
Vienna, VA).
 
Immunoprecipitation
 
Confluent monolayer cultures of stable L transfectants expressing E-43 or
E-43/1–9,49–124 (Yonemura et al., 1993) on 10-cm dishes were used for
immunoprecipitation. All procedures were carried out on ice. Cells were
washed twice with a solution containing 150 mM NaCl, 1 mM CaCl
 
2
 
, 1 mM
MgCl
 
2
 
 and 10 mM Hepes (pH 7.5), and then lysed in 1 ml of lysis buffer
(150 mM NaCl, 1 mM CaCl
 
2
 
, 1 mM MgCl
 
2
 
, 10 mM Hepes [pH 7.5], 0.1%
Nonidet P-40, 1 mM DTT, 20 
 
m
 
g/ml leupeptin) for 30 min. The lysate was
removed from the dish after fully dislodging any remaining cellular debris
with a rubber policeman. After centrifugation at 12,000 
 
g
 
 for 20 min, the
supernatant was incubated for 1 h with 10 
 
m
 
l of protein G–Sepharose 4B
beads (Zymed Labs, Inc., South San Francisco, CA) conjugated with anti–
E-cadherin mAb, ECCD-2. The beads were collected and washed with ly-
sis buffer five times by centrifugation at 1,250 
 
g
 
 for 2 min. The immune
complexes were eluted from the beads in 300 
 
m
 
l of 1 M CH
 
3
 
COOH for 10
min. The supernatant was freeze-dried and separated by SDS-PAGE fol-
lowed by immunoblotting with ECCD-2 or TK89.
 
Results
 
In Vitro Binding of Moesin to GST Fusion Proteins
with CD44, CD43, and ICAM-2
 
We established an in vitro binding assay to evaluate the in-
teraction between recombinant ERM proteins and GST
fusion protein with the cytoplasmic domain of CD44
(Hirao et al., 1996). Using this assay, we first compared the
binding abilities of CD44, CD43, and ICAM-2 to recombi-
nant moesin as a representative ERM protein. GST fusion
proteins with the whole cytoplasmic domain of CD44
(G-44), CD43 (G-43), or ICAM-2 (G-ICAM-2) were puri-
fied on glutathione-Sepharose beads. As controls, GST fu-
sion proteins with the whole cytoplasmic domain of E-cad-
herin (G-E-cad) and occludin (G-Oc) were also purified.
These fusion protein-bound glutathione-Sepharose beads
were incubated with recombinant moesin, washed, and
eluted with glutathione. The eluate contained GST fusion
protein and its associated protein. Moesin association with
GST fusion proteins was evaluated by immunoblotting
with antimoesin mAb followed by densitometry (Fig. 2).
At low ionic strength (40 mM KCl), G-43 and G-44 bound
to moesin with similar affinity. At physiological ionic strength
(150 mM KCl), G-43 still bound to moesin, whereas the
binding ability of G-44 to moesin was significantly decreased
as previously reported (Hirao et al., 1996). G-ICAM-2
bound to moesin with affinity similar to G-43 at physiolog-
ical ionic strength. In contrast, G-E-cad, G-Oc and GST
showed no binding affinity to moesin. Considering that the
dissociation constant between the cytoplasmic domain of
CD44 and moesin at 40 mM KCl is 
 
z
 
10 nM (Hirao et al.,
1996), these findings showed that moesin directly and spe-
cifically binds to the cytoplasmic domains of CD43 and
ICAM-2 at physiological ionic strength. We checked here
that ezrin also bound to CD43 (data not shown), but other
binding combinations remain to be examined.
 
Moesin-binding Sites in the Cytoplasmic Domain of 
CD44 and CD43
 
Because there is no significant homology among the cyto-
plasmic domains of CD44, CD43, and ICAM-2, we at-
tempted to define the region responsible for moesin bind-
ing of each protein. Mouse CD44, rat CD43, and mouse
ICAM-2 have 70, 124, and 28 amino acids in their cyto-
plasmic domains, respectively. We then constructed vari-
ous deletion series of GST–CD44 and GST–CD43 fusion
proteins (Fig. 1 
 
a
 
), and performed an in vitro binding assay
Figure 2. Association of moesin with the cytoplasmic domains of
CD44, CD43, and ICAM-2. GST (GST) or GST fusion proteins
with the entire cytoplasmic domain of E-cadherin (G-E-cad), oc-
cludin (G-Oc), CD43 (G-43), CD44 (G-44), or ICAM-2 (G-ICAM-2)
were bound to Glutathione-Sepharose beads, and incubated with
purified recombinant moesin at physiological (150 mM KCl) or
low ionic strength (40 mM KCl). After washing, GST or GST fu-
sion proteins were eluted together with their binding proteins
from the beads with a buffer-containing glutathione. Proteins in
the glutathione eluate were separated by SDS-PAGE followed
by Coomassie brilliant blue staining to densitometrically estimate
the amount of GST or GST fusion proteins in each eluate (GST
fusion), or followed by immunoblotting with antimoesin mAb
M22 to densitometrically estimate the amount of moesin bound
to GST or GST fusion proteins (Bound Moesin). Relative bind-
ing ability of GST fusion proteins to moesin (Relative Binding of
Moesin) was calculated by comparing the amount of bound
moesin in each eluate containing a constant amount of nonde-
graded GST fusion protein with that in G-43 (150 mM KCl) elu-
ate, with a careful attention to the effects of degradation products
on the binding data. Values represent relative binding abilities
averaged from three experiments 6 SEM. 
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using recombinant moesin at physiological ionic strength.
As shown in Fig. 3 
 
a
 
, in the CD44 deletion series, G-44/1–19
and G-44/1–31 bound to moesin whereas G-44/19–70 did
not. This indicates that the amino acid sequence of the
juxta-membrane region (a.a.1–19) is responsible for moesin
binding. The binding affinities of G-44/1–19 and G-44/1–31
to moesin at 150 mM KCl were similar to that of G-44 at
40 mM KCl (
 
K
 
d
 
 
 
5
 
 
 
z
 
10 nM), suggesting an intramolecular
suppressive interaction between the amino- and carboxyl-
terminal parts of the cytoplasmic domain of CD44 under
physiological conditions. We also found that G-44/1–19 and
G-44/1–31 bound to ezrin and radixin with affinity similar
to moesin under physiological conditions (data not shown).
The CD43 deletion series yielded rather complex results
(Fig. 3 
 
b
 
). G43/1–31 and G43/62–124 bound to moesin with
affinities similar to the full-length cytoplasmic domain of
CD43 (G-43). However, a construct longer than G-43/1–31
(G-43/1–39) weakly bound to moesin, and that longer than
G-43/62–124 (G-43/38–124) also showed weak binding.
Furthermore, G-43/1–64 and G-43/78–124 hardly bound to
moesin. These observations indicate that there are two
moesin-binding regions in the cytoplasmic domain of
CD43 at least in vitro. One is located in the juxta-mem-
brane domain (a.a.1–31) and the other is in the middle
part of the cytoplasmic domain (a.a.62–78). The region be-
tween these two domains (a.a.32–61) appeared to be in-
hibitory for moesin binding. Similar results were obtained
using ezrin (data not shown).
 
Colocalization of E-cadherin Chimeric Molecules 
Containing Cytoplasmic Domains of CD44, CD43, and 
ICAM-2 with ERM Proteins in Transfected Cells and 
Responsible Domains
 
To assess the physiological relevance of the above in vitro
binding results, we constructed and introduced E-cadherin
chimeric molecules consisting of the extracellular domain
of E-cadherin and whole or various deletion constructs of
the transmembrane/cytoplasmic domain of CD44, CD43,
or ICAM-2 (Fig. 1 
 
b
 
) into mouse L fibroblasts that did not
express any endogenous E-cadherin. Using an anti–E-cad-
herin mAb specific for the extracellular domain of E-cad-
herin, we then compared their subcellular distributions
with those of ERM proteins by immunofluorescence mi-
croscopy. In parent L cells, ezrin, radixin, and moesin
were precisely colocalized at microvilli, and the full-length
E-cadherin introduced in L cells was not concentrated at
microvilli (data not shown; see Yonemura et al., 1993). Be-
cause in L cells moesin was predominant among ERM
proteins, the data obtained with antimoesin mAb (CR-22)
are shown here.
As shown in Fig. 4 
 
a
 
, E-44 containing the full-length cy-
toplasmic domain of CD44 was co-concentrated with
moesin at microvilli. Considering that endogenous CD44
was reported to be colocalized with moesin in microvilli of
cultured fibroblasts (Tsukita et al., 1994), this finding indi-
cates that the cytoplasmic, but not the extracellular do-
Figure 3. Comparison of the
moesin-binding ability among
various truncated cytoplas-
mic domains of CD44 (a) and
CD43 (b). GST fusion pro-
teins (Fig. 1 a) or GST were
incubated with moesin at
150 mM KCl. Relative bind-
ing ability of each GST fu-
sion protein to moesin was
calculated as explained in
Fig. 2. Relative-binding abili-
ties of G-44/1–31 and G-43
were defined as 1 in a and b,
respectively. In CD44, a.a.1–19
and a.a.1–31 (thick lines, bot-
tom, a) bound to moesin with
similar affinity to the whole
cytoplasmic domain of CD44
at 40 mM KCl, whereas
a.a.19–70 as well as a.a.1–70
showed very low affinity to
moesin (broken lines, bottom,
a), indicating that a.a.1–19 are
responsible for moesin bind-
ing of CD44 (Fig. 2) and that
a.a.19–70 are inhibitory for
moesin binding of CD44. In
CD43, a.a.1–31 and a.a.62–
124 strongly bound to moesin
with similar affinity to the
whole cytoplasmic domain of CD43 (thick lines, bottom, b), a.a.1–39 and a.a.38–124 were rather weakly associated with moesin (thin
lines, bottom, b), and a.a.1–64 and a.a.78–124 showed very low affinity to moesin (broken lines, bottom, b). These findings indicate that
at least in vitro both a.a.1–31 and a.a.62–78 appear to be responsible for moesin binding of CD43 (Fig. 2), and that the other region is in-
hibitory for moesin binding of CD43. 
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main of CD44 is responsible for its co-concentration with
moesin in microvilli. We constructed various cytoplasmic
domain deletion mutants of this chimeric molecule and in-
troduced them into L cells (Fig. 1 b). E-44/1–19 (Fig. 4, c
and d) as well as E-44/1–32 (data not shown) colocalized
with moesin at microvilli, whereas E-44/20–70 was dif-
fusely distributed over the cell surface and not concen-
trated at microvilli (Fig. 4, e and f). These observations in-
dicated that the juxta-membrane region (a.a.1–19) of the
cytoplasmic domain of CD44 is sufficient for E-cadherin–
CD44 chimeric molecules to colocalize with moesin at mi-
crovilli (see Fig. 7).
In our previous study using the same transfection sys-
tem, we found that E-43, which contains the full-length cy-
toplasmic domain of CD43, was co-concentrated with
moesin at microvilli, and that E-43/1–47 was also colocal-
ized with moesin, whereas E-43/1–9,49–124 was not con-
centrated at microvilli (Yonemura et al., 1993; see Fig. 7).
In this study, to further define the responsible domain,
E-43/1–31 was introduced into L cells (Fig. 5, a and b).
E-43/1–31 was highly concentrated at microvilli together
with moesin, indicating that the juxta-membrane region
(a.a.1–31) of the cytoplasmic domain of CD43 is responsi-
ble for colocalization of these E-cadherin–CD43 chimeric
molecules with moesin.
We also produced an E-cadherin chimera with the whole
cytoplasmic domain of ICAM-2 (E-ICAM-2) and trans-
fected it into L cells. As shown in Fig. 5, c and d, this mole-
cule was again highly concentrated at microvilli together
with moesin.
Coimmunoprecipitation of ERM Proteins with E-43 
from L Cell Transfectants
The association of ERM proteins with CD44 inside cells
was detected by immunoprecipitation from BHK cells, but
the detection of ERM protein–integral membrane protein
complex by immunoprecipitation was difficult, because
the molecular complex resists the detergent extraction due
to its tight association with actin-based cytoskeletal com-
ponents (Tsukita et al., 1994). However, probably because
relatively large amounts of E-cadherin–CD43 chimeric mole-
cules appeared on the cell surface of L cell transfectants,
and probably because anti–E-cadherin mAb was very po-
tent for immunoprecipitation, we were able to compare
the amounts of ERM proteins in E-cadherin immunopre-
cipitates from E-43 stable transfectants with that from
E-43/1–9,49–124 stable transfectants (in the former trans-
fectants E-43 was co-concentrated with moesin at mi-
crovilli, whereas in the latter E-43/1–9,49–124 was not [see
Fig.7]). As shown in Fig. 6, ERM proteins were coimmu-
noprecipitated with E-43, but not with E-43/1–9,49–124.
This finding indicates not only that the juxta-membrane
domain of CD43 is responsible for the CD43–ERM pro-
Figure 4. Immunofluores-
cence localization of E-cad-
herin chimeric molecules with
entire and truncated cyto-
plasmic domains of CD44
(Fig. 1 b). L cells transiently
expressing E-44 (a and b),
E-44/1–19 (c and d) or E-44/
20–70 (e and f) were doubly
stained with anti–E-cadherin
antibody (a, c, and e) and an-
timoesin antibody (b, d, and
f). Both E-44 and E-44/1–19
were precisely co-concen-
trated with moesin at mi-
crovilli (arrows), whereas
E-44/20–70 was diffusely dis-
tributed on cell surface, indi-
cating that the ERM-colocal-
ization signal resides in
a.a.1–19 of the cytoplasmic
domain of CD44. Bar, 20 mm.Yonemura et al. Binding Partners for ERM Proteins 891
teins interaction, but also that the L cell transfection system
with E-cadherin chimeric molecules is useful for evalua-
tion of ERM protein–integral membrane protein interaction.
In E-ICAM-2 stable transfectants, the cell surface expres-
sion level of E-ICAM-2 was not sufficient for immunopre-
cipitation analyses.
Positively Charged Amino Acid Clusters Responsible 
for ERM Protein–Integral Membrane Protein Binding
As summarized in Fig. 7, in vitro binding analysis identi-
fied a.a.1–19 of the cytoplasmic domain of CD44, a.a.1–31,
and 62–78 of the cytoplasmic domain of CD43, and the
whole cytoplasmic domain (a.a.1–28) of ICAM-2 as
moesin-binding sites. On the other hand, transfection ex-
periments with E-cadherin chimeric molecules indicated
that a.a.1–19 of CD44-, a.a.1–31 of CD43-, and a.a.1–28 of
ICAM-2 cytoplasmic domains are responsible for co-con-
centration of these integral membrane proteins with ERM
proteins at microvilli. Together with the results obtained
from immunoprecipitation analysis, we concluded that the
in vitro moesin–binding ability of a.a.62–78 of the CD43–
Figure 5. Immunofluores-
cence localization of E-cad-
herin chimeric molecules with
the truncated cytoplasmic do-
main of CD43 (a and b; E-43/
1–31) or the entire cytoplas-
mic domain of ICAM-2 (c
and  d;  E-ICAM-2) (Fig. 1 b).
L cells transiently expressing
each protein were doubly
stained with anti–E-cadherin
antibody (a and c) and anti-
moesin antibody (b and d).
Both chimeric proteins were
precisely co-concentrated with
moesin at microvilli (arrows).
Bars, 20 mm.
Figure 6. Coimmunoprecipi-
tation of ERM proteins with
E-cadherin chimeric protein
with the whole cytoplasmic
domain of CD43 (E-43). Cul-
tured L cell transfectants ex-
pressing E-43 or E-43/1–9,
49–124 were solubilized with
a lysis buffer containing 0.1%
Nonidet P-40, and then im-
munoprecipitated with anti–
E-cadherin mAb. The immu-
noprecipitate was separated
by SDS-PAGE followed by
immunoblotting with anti-
ERM protein pAb (TK89;
Anti-ERM) or anti–E-cadherin
mAb (Anti–E-cad). TK89
recognized ezrin (E)/radixin (R) as well as moesin (M). ERM
proteins were coimmunoprecipitated with E-43, but not with
E-43/1–9,49–124.
Figure 7. Comparison of the results obtained from in vitro bind-
ing studies with transfection studies. Hatched squares represent
the regions in cytoplasmic domains of CD44, CD43, and ICAM-2,
which are responsible for their in vitro–direct binding to moesin
(Fig. 3). In transfection experiments, E-cadherin chimeric mole-
cules containing cytoplasmic regions represented as thick lines
were co-concentrated with moesin at microvilli, whereas those
containing regions represented by broken lines were diffusely dis-
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cytoplasmic domain was not indispensable in the cells, and
that the juxta-membrane 20–30-amino acid sequence of
the cytoplasmic domains of CD44, CD43, and ICAM-2
can bind to ERM proteins and recruit these integral mem-
brane proteins to microvilli together with ERM proteins.
These three juxta-membrane domains showed no signif-
icant similarity in their amino acid sequences, but they
were characterized by many positively charged amino ac-
ids, such as R and K (Fig. 8). To evaluate the importance
of the positively charged amino acid clusters of CD44,
CD43, and ICAM-2 in their binding to ERM proteins, we
substituted the juxta-membrane KKK in G-44, KRR in G-43,
and RRR in G-ICAM-2 with QIN, NGG, and GGA, re-
spectively (Fig. 8). Using these site-directed mutants of
GST fusion proteins (G-44/KKK:QIN, G-43/KRR:NGG,
and G-ICAM-2/RRR:GGA, respectively) and recombinant
moesin, we then performed an in vitro binding assay. As
shown in Fig. 9, all of the mutant proteins lost their bind-
ing ability to moesin. Furthermore, when E-cadherin chi-
meric molecules with corresponding mutants (E-44/KKK:
QIN, E-43/KRR:NGG, and E-ICAM-2/RRR:GGA) were
constructed and introduced into L cells, all of these mole-
cules were distributed diffusely on the cell surface (Fig.
10). They were not excluded from microvilli, but were not
co-concentrated with moesin at microvilli. These findings
indicated the importance of the juxta-membrane posi-
tively charged amino acid clusters in the ERM protein–
integral membrane interaction.
Discussion
Binding of ERM Proteins to CD43 and ICAM-2
As Well As CD44 through Their Juxta-Membrane 
Positively Charged Amino Acid Clusters
In this study, we first compared CD43 and ICAM-2 with
CD44 in terms of moesin association in vitro. Close analy-
ses using various deletion mutants revealed that moesin
bound in vitro to juxta-membrane positively charged
amino acid clusters of these membrane proteins. Judging
from the affinity of moesin–CD44 binding (Kd 5 z10 nM;
Hirao et al., 1996), moesin binding to the clusters of CD43
and ICAM-2 appeared to be physiologically significant.
Next, by transfecting various mutants of E-cadherin/
CD-44 (E-44), E-cadherin/CD-43 (E-43), and E-cadherin/
ICAM-2 (E-ICAM-2) chimeric molecules into L cells, we
narrowed down the domains that were required for their
colocalization with moesin at microvilli, and found that
their juxta-membrane positively charged amino acid clus-
ters were again responsible. These observations, together
with the results of immunoprecipitation and site-directed
mutagenesis studies, led us to conclude that moesin bound
not only to the juxta-membrane region of CD44 but also
to those of CD43 and ICAM-2 in vivo.
Most of the in vitro data presented here were from ex-
periments using recombinant moesin, but we also con-
firmed that ezrin and radixin behaved in the same manner
as moesin in several experiments. CD44 was reported to
be associated with not only moesin but also ezrin and ra-
dixin both in vitro and in vivo (Tsukita et al., 1994; Hirao
et al., 1996). Furthermore, in this study, ezrin and radixin,
Figure 8. Amino acid sequences of the juxta-membrane cytoplas-
mic domains of CD43 and CD44 and the entire cytoplasmic do-
main of ICAM-2 that are responsible for their ERM binding and
ERM colocalization (Fig. 7). Positively charged amino acid resi-
dues are presented in bold letters. By in vitro mutagenesis, posi-
tively charged amino acid clusters, which were underlined in
CD44, CD43, and ICAM-2, were substituted with noncharged
amino acids to construct E-44/KKK:QIN, E-43/KRR:NGG, and
E-ICAM-2/RRR:GGA, respectively. These sequence data are
available from EMBL/GenBank/DDBJ under accession number
Y00090 (rat CD43), X66081 (mouse CD44), and X6549/S46669
(mouse ICAM-2).
Figure 9. Moesin-binding abilities of site-directed mutants of the
cytoplasmic domains of CD44, CD43, and ICAM-2. GST fusion
proteins with the entire cytoplasmic domains of CD43 (G-43) and
the site-directed mutants of CD43, CD44, and ICAM-2 (G-43/
KRR:NGG, G-44/KKK:QIN, and G-ICAM-2/RRR:GGA; Fig. 8)
were incubated with moesin at 150 mM KCl (for G-43/KRR:
NGG and G-ICAM-2/RRR:GGA) or at 40 mM KCl (for G-44/
KKK:QIN). Relative-binding ability of each GST fusion protein
to moesin was calculated as explained in Fig. 2. Relative-binding
ability of G-43 was defined as 1. As compared to G-43, the site-
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as well as moesin, were coimmunoprecipitated with E-43,
and all ERM proteins were colocalized with E-44, E-43,
and E-ICAM-2 in L cell transfectants. We therefore con-
cluded that not only moesin, but also ezrin and radixin,
bound to the juxta-membrane region of CD43, ICAM-2,
as well as CD44.
Specificity of the Binding of ERM
Proteins to the Juxta-Membrane Positively Charged 
Amino Acid Clusters
Most of the transmembrane proteins have positively
charged amino acid residues in their juxta-membrane re-
gions, and these residues are thought to form an anchor,
arresting translocation across the bilayer during biosyn-
thesis and assuring the correct topological orientation of
membrane proteins (Boyde and Beckwith, 1990). For ex-
ample, there are several positively charged amino acid res-
idues in the juxta-transmembrane domains of E-cadherin
and occludin, which did not bind to ERM proteins. As
shown in Table I, we found that the balance of positively
and negatively charged amino acid residues in the whole
cytoplasmic domain was significantly different between
ERM-binding proteins such as CD44, CD43, and ICAM-2,
and ERM-nonbinding proteins such as E-cadherin and oc-
cludin. The calculated isoelectric points of the whole cyto-
plasmic domains of CD44, CD43, ICAM-2, E-cadherin,
and occludin were 8.17, 9.24, 12.98, 3.89, and 5.85, respec-
tively, indicating that, at neutral pH, CD44, CD43, and
Figure 10. Immunofluores-
cence localization of site-
directed mutants of E-cadherin
chimeric molecules with en-
tire cytoplasmic domains of
CD44, CD43, and ICAM-2.
KKK, KRR, and RRR in the
juxta-membrane regions of
CD44, CD43, and ICAM-2
were substituted with non-
charged amino acids, respec-
tively (E-44/KKK:QIN, E-43/
KRR:NGG, and E-ICAM-2/
RRR:GGA) (Fig. 8). L cells
transiently expressing these
mutants were doubly stained
with anti–E-cadherin anti-
body (a, c, and e) and anti-
moesin antibody (b, d, and f).
These mutants were diffusely
distributed on the cell surface
and were never concentrated
at microvilli. Bar, 20 mm.
Table I. Calculated Isoelectric Points of Cytoplasmic Domains
Integral
membrane protein
Calculated
isoelectric point
ERM
binding
CD44 8.17 Weak
CD43 9.24 Strong
ICAM-2 12.98 Strong
E-cadherin 3.89 Undetectable
Occludin 5.85 Undetectable
The isoelectric points were calculated using a program from GENETYX software
package (Software Development Co., Tokyo, Japan) using the sequence data obtained
from EMBL/GenBank/DDBJ under accession numbers X66081 (mouse CD44),
Y00090 (rat CD43), X6549 or S46669 (mouse ICAM-2), X06115 (mouse E-cadherin),
and D21837 (chick occludin).The Journal of Cell Biology, Volume 140, 1998 894
ICAM-2 have a net positive charge over their whole cyto-
plasmic domain and that E-cadherin and occludin have a
net negative charge.
Several integral membrane proteins, L-selectin (Picker
et al., 1991), ICAM-1 (Carpén et al., 1992), integrins a4b7
and a4b1 (Berlin et al., 1995), and P-selectin glycoprotein
ligand-1 (Moore et al., 1995) were reported to be localized
at microvilli. L-selectin and ICAM-1 have short cytoplasmic
domains (z10 and z30 amino acids, respectively) and their
net charges are highly positive. It is postulated that a-acti-
nin is a membrane–cytoskeleton linker for these membrane
proteins. However, L-selectin lacking the a-actinin–binding
site, which bears only a positively charged six–amino acid
cytoplasmic domain (RRLKKG), is still localized at mi-
crovilli (Carpén et al., 1992; Pavalko et al., 1995), and ICAM-1
was reported to associate with ezrin (Helander et al.,
1996). Both a4 integrin and P-selectin glycoprotein ligand-1
have positively charged amino acid clusters of z30 amino
acids in their juxta-membrane region.
Taken together, for integral membrane proteins, the
positively charged amino acid cluster in the juxta-mem-
brane cytoplasmic domain might be a default signal for
ERM binding and/or microvillar localization within cells.
When the positively charged amino acid cluster is followed
by a negatively charged amino acid cluster, i.e., the net
charge of the whole cytoplasmic domain is negative or
nearly neutral, the former cluster may be masked by the
latter, losing its binding ability to ERM proteins. This
hypothesis may explain the binding ability of integral
membrane proteins to ERM proteins. However, the ERM-
binding or ERM-colocalization ability of some of the trun-
cated or site-directed mutants cannot be explained by this
hypothesis. For example, although the isoelectric point of
the cytoplasmic domain of E-43/1–64 was calculated as
10.73, this mutant does not bind to moesin (Fig. 3 b). The
cytoplasmic domain of E-ICAM-2/RRR:GGA also has a
net positive charge, but does not colocalize with moesin
(Fig. 9). These findings suggest that the three-dimensional
structure in or around the juxta-membrane positively charged
amino acid clusters is also important for the specificity of
ERM protein–integral membrane protein interaction.
Physiological Relevance of the Occurrence of Multiple 
Membrane Binding Partners for ERM Proteins
At present, it is not clear how many types of integral mem-
brane proteins function as binding partners for ERM pro-
teins in situ, but judging from the expression and distribu-
tion of CD44, CD43, and ICAM-2 in tissues, the occurrence
of many other ERM-binding partners can be expected. In
cells within tissues, as yet undetermined regulatory mecha-
nisms may determine the combination of ERM proteins
and their membrane-binding partners, resulting in the spe-
cific expression and distribution of ERM proteins in a cell
type-specific manner (Franck et al., 1993; Amieva et al., 1994).
We found previously that at physiological ionic strength
the association between CD44 and ERM proteins requires
PIP2 in vitro, and that it is regulated by the Rho signaling
pathway in vivo, which is thought to generally regulate ac-
tin-based cytoskeletal organization (Hirao et al., 1996).
However, in marked contrast to CD44, even at physiologi-
cal ionic strength, CD43 and ICAM-2 bound to ERM pro-
teins in vitro with a relatively high affinity in the absence
of PIP2. It is not clear at present whether the binding of
ERM proteins to CD43 and ICAM-2 (and to as yet uni-
dentified ERM membrane-binding partners) in vivo is also
regulated by the Rho signaling pathway. Although this
study was focused on the identification of membrane-
binding partners other than CD44 and on their ERM pro-
tein-binding sites (positively charged amino acid clusters),
the data obtained here would also provide some clues to
understand the regulatory mechanism of ERM–mem-
brane interaction in general. For example, the carboxyl
terminus–truncated CD44 binds to ERM proteins in vitro
even in the absence of PIP2 at physiological ionic strength.
Studies are currently underway in our laboratory to clarify
the regulatory mechanism of ERM–membrane interaction.
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